Tme Pharma N.v. Stock
€0.16
Your prediction
Financial data and news for Tme Pharma N.v.
sharewise wants to provide you with the best news and tools for Tme Pharma N.v., so we directly link to the best financial data sources.
Financials
News
TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME)
TME Pharma Announces Oral Presentation of NOX-A12 GLORIA Phase 1/2 Trial in Glioblastoma at ESMO Congress 2024
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME)